Get the Stockscreener App
11.60
1.13%
0.13
After Hours:
11.61
0.010
+0.09%
10 X Genomics Inc stock is traded at $11.60, with a volume of 1.54M.
It is up +1.13% in the last 24 hours and down -8.23% over the past month.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
See More
Previous Close:
$11.47
Open:
$11.68
24h Volume:
1.54M
Relative Volume:
0.55
Market Cap:
$1.33B
Revenue:
$631.73M
Net Income/Loss:
$-239.78M
P/E Ratio:
-5.7426
EPS:
-2.02
Net Cash Flow:
$-33.45M
1W Performance:
-8.23%
1M Performance:
-8.23%
6M Performance:
+44.82%
1Y Performance:
-28.66%
1-Day Range:
$11.35
$11.72
1-Week Range:
$11.18
$12.74
52-Week Range:
$6.78
$18.21
10 X Genomics Inc Stock (TXG) Company Profile
Name
10 X Genomics Inc
Sector
Industry
Phone
(925) 401-7300
Address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
11.60 | 1.43B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
286.09 | 46.97B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
94.47 | 16.75B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.50 | 12.29B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.23 | 7.80B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.16 | 6.81B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-25 | Initiated | Piper Sandler | Neutral |
| Feb-13-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-22-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-18-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-10-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-25-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-03-24 | Resumed | Jefferies | Hold |
| May-01-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-10-23 | Initiated | Barclays | Overweight |
| Mar-31-23 | Initiated | Stephens | Overweight |
| Feb-02-23 | Initiated | UBS | Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Aug-18-22 | Downgrade | Goldman | Neutral → Sell |
| Jul-25-22 | Initiated | Canaccord Genuity | Buy |
| Jul-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-15-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-14-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-15-21 | Initiated | William Blair | Outperform |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Overweight |
| Jul-10-20 | Initiated | Stifel | Buy |
| Mar-05-20 | Initiated | Guggenheim | Buy |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-07-19 | Initiated | BofA/Merrill | Buy |
| Oct-07-19 | Initiated | Cowen | Outperform |
| Oct-07-19 | Initiated | JP Morgan | Overweight |
| Sep-24-19 | Initiated | Evercore ISI | Outperform |
View All
10 X Genomics Inc Stock (TXG) Latest News
Is 10x Genomics Inc. stock entering bullish territoryJuly 2025 Drop Watch & Daily Market Momentum Tracking - newser.com
How geopolitical tensions affect 10x Genomics Inc. stock2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Using flow based indicators on 10x Genomics Inc.Market Trend Summary & Technical Confirmation Trade Alerts - newser.com
Single-cell Analysis Market to Reach USD 12.29 Billion by 2032, Driven by Expanding Oncology Research and Advanced Genomics – SNS Insider - GlobeNewswire Inc.
What’s the recovery path for long term holders of 10x Genomics Inc.Earnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Advanced analytics toolkit walkthrough for 10x Genomics Inc.Trade Exit Summary & Weekly High Potential Stock Alerts - newser.com
Is 10x Genomics Inc. (1KJ) stock bottoming after sell off2025 Trade Ideas & Real-Time Stock Price Movement Reports - newser.com
10X Genomics Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges - Markets Mojo
10x Genomics (NASDAQ:TXG) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025 - Eastern Progress
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know - Yahoo Finance
Trifecta Capital Advisors LLC Makes New $338,000 Investment in 10x Genomics $TXG - MarketBeat
10x Genomics To Report Third Quarter 2025 Financial Results On November 6, 2025 - Barchart.com
Can 10x Genomics Inc. stock deliver surprise earnings beatWeekly Profit Summary & Safe Entry Trade Reports - newser.com
Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns - MSN
10X Genomics Hits Day Low of $11.54 Amid Price Pressure - Markets Mojo
10x Genomics (NASDAQ:TXG) Trading Down 7.6%What's Next? - MarketBeat
Why 10x Genomics Inc. (1KJ) stock stays on top picksWall Street Watch & Safe Capital Growth Tips - newser.com
How to use a screener to detect 10x Genomics Inc. breakoutsTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Public Employees Retirement System of Ohio Raises Position in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Upgraded to "Buy" at Wall Street Zen - MarketBeat
61,470 Shares in 10x Genomics $TXG Purchased by Lecap Asset Management Ltd. - MarketBeat
What analysts say about 10x Genomics Inc stockInstitutional Holding Changes & Small Investment Trading Plans - earlytimes.in
4 Best Genetic Sequencing Stocks To Buy in 2025 - The Motley Fool
Wealth Enhancement Advisory Services LLC Increases Stock Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Pattern recognition hints at 10x Genomics Inc. upside2025 Trading Volume Trends & High Accuracy Swing Trade Signals - newser.com
10x Genomics Aims For Growth Despite Funding Uncertainty - Finimize
Is 10x Genomics Inc. a candidate for recovery play2025 Macro Impact & Weekly Watchlist for Consistent Profits - newser.com
Why 10x Genomics Inc. (1KJ) stock is listed among top recommendationsExit Point & Intraday High Probability Setup Alerts - newser.com
10x Genomics Inc 1KJ Stock Analysis and ForecastFundamental Stock Analysis & Small Investment Growth Tips - earlytimes.in
What analysts say about 10x Genomics Inc 1KJ stockChart Pattern Recognition & Exceptional Capital Investment - Early Times
10x Genomics (TXG): Is the Market Overlooking the Company's True Value? - simplywall.st
78,249 Shares in 10x Genomics $TXG Purchased by Counterpoint Mutual Funds LLC - MarketBeat
10x Genomics $TXG Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Pallas Capital Advisors LLC Purchases 32,996 Shares of 10x Genomics $TXG - MarketBeat
What institutional flow reveals about 10x Genomics Inc.Earnings Beat & Community Supported Trade Ideas - newser.com
Goldman Sachs Group Inc. Has $5.63 Million Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat
Risk Hedge: Does 10x Genomics Inc. offer margin of safety2025 Earnings Impact & Growth Focused Investment Plans - خودرو بانک
Kera Capital Partners Inc. Buys Shares of 31,018 10x Genomics $TXG - MarketBeat
Acadian Asset Management LLC Acquires 254,607 Shares of 10x Genomics $TXG - MarketBeat
Investment Report: Does Future FinTech Group Inc have consistent dividend growthJuly 2025 Outlook & Precise Swing Trade Entry Alerts - khodrobank.com
Insider Trends: Is 10x Genomics Inc. stock a good pick for beginners2025 Key Lessons & Risk Controlled Swing Alerts - خودرو بانک
Layoff Watch: Can 10x Genomics Inc stock outperform in a bear market2025 Market Overview & Comprehensive Market Scan Reports - خودرو بانک
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Grows Stock Position in 10x Genomics $TXG - MarketBeat
Breakouts Watch: Can 10x Genomics Inc. sustain earnings growth2025 Price Momentum & Verified High Yield Trade Plans - خودرو بانک
Can 10x Genomics Inc be the next market leader2025 Momentum Check & Free High Return Stock Watch Alerts - khodrobank.com
Risks Report: Will 10x Genomics Inc outperform its industry peersOil Prices & Smart Investment Allocation Tips - خودرو بانک
Institution Moves: Can 10x Genomics Inc withstand a market correction2025 Historical Comparison & Stepwise Trade Execution Plans - خودرو بانک
10 X Genomics Inc Stock (TXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
10 X Genomics Inc Stock (TXG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Taich Adam | Chief Financial Officer |
Aug 22 '25 |
Sale |
13.79 |
22,315 |
307,657 |
309,273 |
| Hindson Benjamin J. | See Remarks |
Aug 22 '25 |
Sale |
13.79 |
7,486 |
103,209 |
440,888 |
3.29%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):